In 2020, Fidelis Pharmaceuticals made available the first FDA-indexed extended-release buprenorphine formulation (Ethiqa XR®(link is external)) specifically for mice and rats. Recent FDA guidance GFI #256 Compounding Animal Drugs from Bulk Drug Substances has been implemented that may impact the future use of Buprenorphine ER (formerly Buprenorphine SR). Campus Veterinary Services encourages labs to review their use […]